Physician and patient advocacy groups are not happy with the latest effort by the Trump Administration to lower drug costs, saying it takes decisions out of doctors’ hands and will limit treatments for patients.
Physician groups say CMS’ change to drug formularies shifts decisions from doctors’ hands to insurers
